Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.61M Buy
5,732
+27
+0.5% +$6.8K 0.91% 27
2026
Q1
$1.38M Hold
5,705
0.7% 30
2025
Q4
$1.69M Hold
5,705
0.93% 24
2025
Q3
$1.61M Hold
5,705
1.12% 21
2025
Q2
$1.68M Sell
5,705
-25
-0.4% -$6.44K 1.25% 22
2025
Q1
$1.42M Hold
5,730
1.08% 24
2024
Q4
$1.26M Sell
5,730
-50
-0.9% -$11.1K 0.88% 27
2024
Q3
$1.28M Buy
5,780
+76
+1% +$14.9K 0.99% 28
2024
Q2
$987K Hold
5,704
0.82% 35
2024
Q1
$1.09M Sell
5,704
-63
-1% -$11.5K 0.92% 31
2023
Q4
$943K Hold
5,767
0.84% 33
2023
Q3
$809K Sell
5,767
-37
-0.6% -$5.26K 0.79% 36
2023
Q2
$777K Buy
5,804
+156
+3% +$20.1K 0.71% 40
2023
Q1
$740K Hold
5,648
0.73% 41
2022
Q4
$796K Hold
5,648
0.83% 34
2022
Q3
$671K Hold
5,648
0.75% 37
2022
Q2
$797K Hold
5,648
0.88% 33
2022
Q1
$734K Hold
5,648
0.68% 39
2021
Q4
$755K Buy
+5,648
New +$708K 0.68% 38

Other funds holding IBM

Cross Staff Investments's IBM Position: Q2 2026 in Review

Cross Staff Investments increased its IBM (IBM) stake by 0.47% in Q2 2026, buying an estimated $6.8K and bringing the position to 5,732 shares worth $1.61M. The position accounts for 0.91% of the portfolio, ranked #27.

Cross Staff Investments first reported a position in IBM in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.69M in Q4 2025. 1,810 funds tracked by Wall St. Rank hold IBM as of Q2 2026.

  • Cross Staff Investments held 5,732 shares of IBM worth $1.61M as of Q2 2026.
  • Cross Staff Investments bought 27 IBM shares in Q2 2026, an estimated $6.8K.
  • IBM made up 0.91% of Cross Staff Investments's portfolio in Q2 2026, its #27 holding.
  • Cross Staff Investments first reported a position in IBM in Q4 2021 and has held it in 19 quarters since.
  • Cross Staff Investments's IBM position peaked at $1.69M in Q4 2025.
  • 1,810 funds tracked by Wall St. Rank held IBM as of Q2 2026.

Based on Cross Staff Investments's 13F filing for Q2 2026, filed 22 Jul 2026.